Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug ...

GEA Group maintains a conservative balance sheet, helping to shield shareholders from the inherent volatility in capital equipment spending in GEA’s various end markets. The balance sheet sits in a ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.